See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Groupon, Inc. (GRPN) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Groupon, Inc. (GRPN) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 26th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Groupon, Inc. (GRPN - Free Report) : This marketplace which connects consumers to merchants has seen the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Groupon, Inc. Price and Consensus
Groupon, Inc. price-consensus-chart | Groupon, Inc. Quote
Nurix Therapeutics, Inc. (NRIX - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.1% over the last 60 days.
Nurix Therapeutics, Inc. Price and Consensus
Nurix Therapeutics, Inc. price-consensus-chart | Nurix Therapeutics, Inc. Quote
Renalytix Plc : This kidney disease diagnostic solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Renalytix AI PLC Sponsored ADR Price and Consensus
Renalytix AI PLC Sponsored ADR price-consensus-chart | Renalytix AI PLC Sponsored ADR Quote
AbCellera Biologics Inc. (ABCL - Free Report) : This antibody drug development platform provider has seen the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
AbCellera Biologics Inc. Price and Consensus
AbCellera Biologics Inc. price-consensus-chart | AbCellera Biologics Inc. Quote
Smartsheet Inc. : This work management solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 31.7% over the last 60 days.
Smartsheet Price and Consensus
Smartsheet price-consensus-chart | Smartsheet Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.